drugset / Trial / NCT00002394

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

NCT00002394 ↗

Completed 30 enrolled Novartis
Parallel-groupTreatment

Summary

The purpose of this study is to see if it is safe and effective to give Lamisil to HIV-positive patients with thrush (a fungal infection) that has not responded to fluconazole.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Terbinafine Small molecule 1500 mg —
Subject Terbinafine Small molecule 2000 mg —